Matti Nykter

14PUBLICATIONS
130CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cell and nuclear divisionMolecular targetsGene mapping
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 16, 2026
Androgen receptor drives divergent chromatin accessibility programs in benign and malignant prostate epithelial cells.

|Aug 21, 2026
Epithelial interferon-stimulated gene programs modulate chemotherapy sensitivity in colorectal cancer via EPSTI1.

|Apr 10, 2026
Deep Invaginations of Nuclear Envelope Coordinate Spatial Organization of Chromatin in Epithelium.

Elina Mäntylä, Sanna Korpela, Anna Rekonen

|Nov 19, 2025
Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment.

Sebastian Krossa, Maria K Andersen, Elise M Sandholm

|Dec 09, 2024
Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer.

Joonatan Sipola, Aslı D Munzur, Edmond M Kwan

|Nov 16, 2024
Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer.

Antti Kiviaho, Sini K Eerola, Heini M L Kallio

Pageof 3

Frequent Collaborators

4 joint publications

Sinja Taavitsainen

4 joint publications

Alfonso Urbanucci

4 joint publications

Kirsi J Rautajoki

3 joint publications

Antti Kiviaho